Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia

Blood

Volumn 95, Issue 8, 2000, Pages 2637-2644

  Padró, Teresa ^a   Ruiz, Sandra ^a   Bieker, Ralf ^a   Bürger, Horst ^a   Steins, Martin ^a   Kienast, Joachim ^a   Büchner, Thomas ^a   Berdel, Wolfgang E ^a   Mesters, Rolf M ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW BIOPSY; CANCER GROWTH; CANCER REGRESSION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0034655595     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.8.2637.008k07_2637_2644     Document Type: Article

References (57)

1. Gimbrone M, Leapman S, Cotran R, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med. 1972;136:261.
2. Folkman J, Watson K, Ingber O, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989;339:58.
3. Nicosia RF, Tchao R, Leighton J. Interaction between newly formed endothelial channels and carcinoma cells in plasma clot culture. Clin Exp Metastasis. 1986;4:91.
4. Hamada J, Cavanaugh PG, Lotan O, Nicholson G. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br J Cancer. 1992;66:349.
5. Rak JW, Filmus J, Kerbel RS. Reciprocal paracrine interactions between tumor cells and endothelial cells: the angiogenesis progression hypothesis. Eur J Cancer. 1996;32:2438.
6. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:353.
7. Skobe M, Rockwell P, Goldstein N, Vosseler S, Fusenig NE. Halting angiogenesis suppresses carcinoma cell invasion. Nature Med. 1997;3: 1222.
8. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1.
9. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous cell carcinoma. Int J Cancer. 1993;55:738.
10. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143:401.
11. Yamazaki K, Abe S, Takeka H, et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer. 1994;74:2245.
12. Ellis LM, Fidler IJ. Angiogenesis and breast cancer metastasis. Lancet. 1995;346:388.
13. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol. 1995;13:765.
14. Maeda K, Chung YS, Takasuka S, Ogawa Y. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol. 1995;13:477.
15. Wiggins DL, Granai CO, Steinhoff MM, Calabresi P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol. 1995;56:353.
16. Fontanini G, Lucchi M, Vignati S, et al. Angiogenesis as a prognostic indicator of survival in non-small cell lung carcinoma: a prospective study. J Natl Cancer Inst. 1997;89:881.
17. Fernández Aceñero MJ, Fariña González J, Galindo Gallego M, Aragoncillo Ballesteros P. Vascular enumeration as a significant prognosticator for invasive breast carcinoma. J Clin Oncol. 1998;16:1684.
18. Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenasis and progression in multiple myeloma. Br J Haematol. 1994;87:503.
19. Vacca A, Ribatti D, Presta M, et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood. 1999;93:3064.
20. Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L, Dammacco F. Angiogenesis spectrum in the stroma of B-cell non Hodgkin's lymphomas. An immunohistochemical and structural study. Eur J Haematol. 1996;56:45.
21. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1997;150: 815.
22. Shami PJ, Hussong JW, Rodgers GM. Evidence of increased angiogenesis in the bone marrow of patients with acute nonlymphocytic leukemia [abstract]. Blood. 1998;92(suppl 1):512a.
23. AguayoA, Kantarjian H, Talpaz M, et al. Increased angiogenesis in chronic myeloid leukemia and myelodysplastic syndromes [abstract]. Blood. 1998;92(suppl 1):607a.
24. Bennet JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620.
25. Büchner T, Hiddemann W, Wörmann B, et al. Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood. 1999;93:4116.
26. Mukai K, Rosai J, Burgdorf WHC. Localisation of FVIII-R ag in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol. 1980;4:273.
27. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 1996;32A:2474.
28. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34 and BNH9 antibody to H- and Y-antigens - evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994;1:82.
29. Mayurama I, Bell C, Majerus P. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics and on syncytiotrophoblasts of human placenta. J Cell Biol. 1985;101: 363.
30. Vermeulen PB, Libura M, Libura J, et al. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma. Breast Cancer Res Treat. 1997;42:165.
31. Hansen S, Grabau DA, Rose C, Bak M, Sorensen FB. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest. 1998;78:1563.
32. Cheson BC, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8: 813.
33. Vermeulen PB, Verhoven D, Fierens H, et al. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer. 1995;71:340.
34. Stephenson TJ, Mills PM. Monoclonal antibodies to blood group isoantigens: an alternative marker to factor VIII related antigen for benign and malignant vascular endothelial cells. J Pathol. 1985; 147:139.
35. Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia. 1999;13:469.
36. Bhunchet E, Fujieda K. Capillarization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis: a mechanism to maintain liver blood flow. Hepatology. 1993;18:1450.
37. Martinez-Hernandez A, Martinez J. The role of capillarization in hepatic failure: studies in carbon tetrachloride-induced cirrhosis. Hepatology. 1991; 14:864.
38. Dubuisson L, Boussarie L, Bedin CA, Balabaud C, Bioulac-Sage P. Transformation of sinusoids into capillaries in a rat model of selenium-induced nodular regenerative hyperplasia: an immunolight and immunoelectron microscopic study. Hepatology. 1995;21:805.
39. García-Monzón C, Sánchez-Madrid F, García-Buey L, García-Arroyo A, García-Sanchez A, Moreno-Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology. 1995;108:231.
40. Urashima S, Tsutsumi M, Nakase K, Wang JS, Takada A. Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol Suppl. 1993;18:77.
41. Fernig DG, Gallaher JT. Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res. 1994;5:353.
42. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029.
43. Claffey KP, Robinson GS. Regulation of VEGF/ VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev. 1996;15:165.
44. Fiedler W, Graeven U, Ergün S, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood. 1997;89:1870.
45. Senger DR. Molecular frame for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol. 1996;149:1.
46. McWilliam N, Robbie L, Booth N, Bennet B. Plasminogen activator in acute myeloid leukemic marrows: u-PA in contrast to t-PA in normal marrows. Br J Haematol. 1998;101:626.
47. Pui C-H, Evans W. Acute lymphoblastic leukemia. N Engl J Med. 1998;339:605.
48. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Microcirculation. 1997;4:1.
49. Hobson B, Denekamp J. Endothelial proliferation in tumors and normal tissues: continuous labeling studies. Br J Cancer. 1984;49:405.
50. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10,931.
51. Harrison JH, Lazo JS. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther. 1988;243:1185.
52. Hill SA, Lonergan SJ, Denekamp J, Chaplin DJ. Vinca alkaloids: antivascular effects in a murine tumour. Eur J Cancer. 1970;29:2470.
53. Belotti D, Vergani V, Drudis T, at al. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res. 1996;2:1843.
54. Maragoudakis ME, Peristeris P, Missirlis E, Aletras A, Adriopoulou P, Haralabopoulos G. Inhibition of angiogenesis by anthracyclines and titanocene dichloride. Ann N Y Acad Sci. 1994;732: 280.
55. Schirner M, Hoffmann J, Menrad A, Schneider MR. Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res. 1998;4:1331.
56. Davis T, Robinson D, Lee K, Kessler S. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replicating potential: requirement for cell-to-cell interactions and colony-stimulating factors. Blood. 1995;85:1751.
57. Griffin JD, Rambaldi A, Vellenga E, Young DC, Ostapovicz D, Cannistra SA. Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood. 1987;70:1218.